Shelter Pharma Ltd - 543963 - Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Shelter Pharma has confirmed that there was no deviation or variation in the utilization of proceeds from its Preferential Issue of Convertible Warrants. The Rs.25.31 crore raised was used for working capital requirements as approved in the July 2025 EGM, demonstrating compliance.
May 28 2026 17:24:16
Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And
Year Ended March 31, 2026.
Shelter Pharma declared audited FY26 financial results, with net profit increasing 24.73% YoY to ₹902.72 lakhs and revenue growing 44.38% YoY to ₹7,313.36 lakhs. M/S. I I Lakhani & Co. were reappointed as internal auditors for FY27.
May 28 2026 16:39:07
Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May, 2026
Shelter Pharma's Board will convene on May 28, 2026, to consider and approve the audited financial results for the half year and full year ended March 31, 2026. This meeting is crucial for investor insights into the company's annual performance.
May 22 2026 17:17:02
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 International Pharmaceutical Exihibition
Shelter Pharma will participate in the iPHEX 2026 International Pharmaceutical Exhibition from September 7-9, 2026, at Bharat Mandapam. This participation aims to enhance global visibility, strengthen client relationships, and explore new export opportunities for its product portfolio.
May 18 2026 11:07:51
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI (LODR) Regulation, 2015- New Product Launch.
Shelter Pharma launched its new healthcare product, FOLIMAN Folic Acid Tablets, on May 11, 2026. This Vitamin B-9 supplement expands the company's healthcare and nutraceutical portfolio, aiming to strengthen its market presence in international markets.
May 11 2026 11:04:08
Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 05, 2026 For Conversion Of 111000 Warrants Into 111000 Equity Shares Of Face Value Of Rs. 10/-
Shelter Pharma's Board approved the allotment of 111,000 equity shares to warrant holders at Rs. 42.25 per share, converting existing warrants. This increases the company's paid-up equity share capital by 0.66%.
May 05 2026 20:25:50
Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, May 01, 2026.
Shelter Pharma has allotted 114,000 equity shares on May 1, 2026, following the conversion of previously issued warrants by non-promoter warrant holders. This increases the company's paid-up equity share capital to Rs. 16.72 crore.
May 01 2026 12:34:10
Read More